Annotation Detail for TNFRSF10B
Basic Information Top
Gene Symbol: | TNFRSF10B ( CD262,DR5,KILLER,KILLER/DR5,TRAIL-R2,TRAILR2,TRICK2,TRICK2A,TRICK2B,TRICKB,ZTNFR9 ) |
---|---|
Gene Full Name: | tumor necrosis factor receptor superfamily, member 10b |
Band: | 8p21.3 |
Quick Links | Entrez ID:8795; OMIM: 603612; Uniprot ID:TR10B_HUMAN; ENSEMBL ID: ENSG00000120889; HGNC ID: 11905 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Pathway ID | Pathway Name |
---|---|
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04115 | p53 signaling pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04210 | Apoptosis |
Pathway ID | Pathway Name |
---|---|
Apoptosis |
Pathway ID | Pathway Name |
---|---|
200101 | Direct p53 effectors |
200056 | TRAIL signaling pathway |
Pathway ID | Pathway Name |
---|---|
P00006 | Apoptosis signaling pathway |
P00059 | p53 pathway |
Pathway ID | Pathway Name |
---|---|
500257 | TRAIL signaling |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in increased expression of TNFRSF10B protein | increases expression | 17645780 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B | increases expression | 15942663 |
C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of TNFRSF10B mRNA | increases expression | 16788091 |
C480030 | 4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid | 4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid results in increased expression of TNFRSF10B protein | increases expression | 15930313 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased expression of TNFRSF10B mRNA | increases expression | 12203115 |
C120508 | A 192621 | A 192621 results in increased expression of TNFRSF10B mRNA | increases expression | 19040731 |
C103303 | alitretinoin | alitretinoin results in increased expression of TNFRSF10B mRNA | increases expression | 16449964 |
D001151 | Arsenic | [Arsenic co-treated with Fluorides] results in increased expression of TNFRSF10B mRNA | affects cotreatment|increases expression | 19962721 |
C006632 | arsenic trioxide | bortezomib promotes the reaction [arsenic trioxide results in increased activity of TNFRSF10B] | increases activity|increases reaction | 20471514 |
C015001 | arsenite | arsenite results in increased expression of TNFRSF10B mRNA | increases expression | 18585952 |
C015001 | arsenite | XPA protein affects the reaction [arsenite results in increased expression of TNFRSF10B mRNA] | affects reaction|increases expression | 18585952 |
D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of TNFRSF10B mRNA | increases expression | 18687144 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of TNFRSF10B mRNA | increases expression | 20064835 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNFRSF10B mRNA | decreases expression | 19150397 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TNFRSF10B protein | increases expression | 16287099 |
C400082 | bortezomib | bortezomib promotes the reaction [arsenic trioxide results in increased activity of TNFRSF10B] | increases activity|increases reaction | 20471514 |
C006862 | butylphen | butylphen results in increased expression of TNFRSF10B protein | increases expression | 15816839 |
D002699 | Chlorambucil | Chlorambucil affects the expression of TNFRSF10B protein | affects expression | 14614459 |
D002699 | Chlorambucil | Chlorambucil results in increased expression of TNFRSF10B mRNA | increases expression | 18092340 |
D002699 | Chlorambucil | Chlorambucil results in increased expression of TNFRSF10B protein | increases expression | 18092340 |
D003042 | Cocaine | Cocaine affects the expression of TNFRSF10B mRNA | affects expression | 15681117 |
D003474 | Curcumin | Curcumin results in decreased expression of TNFRSF10B mRNA | decreases expression | 16101141 |
D003474 | Curcumin | Curcumin results in increased expression of TNFRSF10B protein | increases expression | 18226269 16613838 |
D003474 | Curcumin | TNFRSF10B protein results in increased susceptibility to Curcumin | increases response to substance | 16613838 |
D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of TNFRSF10B protein] | increases expression|increases reaction | 18226269 |
D003474 | Curcumin | Curcumin results in increased expression of TNFRSF10B | increases expression | 18462866 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of TNFRSF10B mRNA | increases expression | 20106945 |
D004052 | Diethylnitrosamine | TNFRSF10B protein results in decreased susceptibility to Diethylnitrosamine | decreases response to substance | 18079962 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of TNFRSF10B protein | increases expression | 17849272 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of TNFRSF10B mRNA | increases expression | 16705698 17922852 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of TNFRSF10B protein | increases expression | 17922852 15897917 |
D004317 | Doxorubicin | TNFRSF10B protein affects the susceptibility to Doxorubicin | affects response to substance | 16098063 17922852 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of TNFRSF10B mRNA | increases expression | 16243910 |
D005047 | Etoposide | Etoposide promotes the reaction [TP53 protein binds to TNFRSF10B promoter] | affects binding|increases reaction | 15964798 |
D005047 | Etoposide | Etoposide results in increased expression of TNFRSF10B mRNA | increases expression | 15964798 |
C024352 | fludarabine | fludarabine affects the expression of TNFRSF10B protein | affects expression | 14614459 |
C024352 | fludarabine | fludarabine results in increased expression of TNFRSF10B mRNA | increases expression | 18092340 |
C024352 | fludarabine | fludarabine results in increased expression of TNFRSF10B protein | increases expression | 18092340 |
D005459 | Fluorides | [Arsenic co-treated with Fluorides] results in increased expression of TNFRSF10B mRNA | affects cotreatment|increases expression | 19962721 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of TNFRSF10B mRNA | increases expression | 17982676 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of TNFRSF10B protein | increases expression | 15585621 |
D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFRSF10B mRNA] | increases expression|increases reaction | 17982676 |
D005472 | Fluorouracil | TNFRSF10B protein results in increased susceptibility to Fluorouracil | increases response to substance | 15374982 |
D005492 | Folic Acid | Folic Acid affects the expression of TNFRSF10B mRNA | affects expression | 16361273 |
D019833 | Genistein | Genistein results in decreased expression of TNFRSF10B mRNA | decreases expression | 16705744 |
C412815 | GW 4064 | GW 4064 results in decreased expression of TNFRSF10B mRNA | decreases expression | 14623915 |
D017313 | Fenretinide | Fenretinide promotes the reaction [DDIT3 protein results in increased expression of TNFRSF10B mRNA] | increases expression|increases reaction | 17273769 |
D017313 | Fenretinide | Fenretinide results in increased expression of TNFRSF10B mRNA | increases expression | 17273769 |
D017313 | Fenretinide | Fenretinide results in increased expression of TNFRSF10B protein | increases expression | 15735044 17273769 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of TNFRSF10B | increases expression | 18687144 |
C031927 | hydroquinone | hydroquinone results in decreased expression of TNFRSF10B mRNA | decreases expression | 15452088 |
D007530 | Isoflurane | Isoflurane results in decreased expression of TNFRSF10B mRNA | decreases expression | 16978161 |
D008727 | Methotrexate | Methotrexate results in increased expression of TNFRSF10B protein | increases expression | 17637740 |
C066851 | mithramycin A | mithramycin A inhibits the reaction [Quercetin results in increased expression of TNFRSF10B mRNA] | decreases reaction|increases expression | 18980244 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of TNFRSF10B mRNA | increases expression | 18955075 |
C058815 | N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide | N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide results in increased expression of TNFRSF10B protein | increases expression | 15520213 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of TNFRSF10B mRNA | increases expression | 14623915 |
D009637 | Nordihydroguaiaretic Acid | Nordihydroguaiaretic Acid results in increased expression of TNFRSF10B mRNA | increases expression | 17645780 |
D009637 | Nordihydroguaiaretic Acid | Nordihydroguaiaretic Acid results in increased expression of TNFRSF10B protein | increases expression | 17645780 |
C482205 | nutlin 3 | nutlin 3 results in increased expression of TNFRSF10B mRNA | increases expression | 16439677 18092340 |
C482205 | nutlin 3 | nutlin 3 results in increased expression of TNFRSF10B protein | increases expression | 18092340 |
D009761 | Nystatin | Nystatin inhibits the reaction [Quercetin affects the localization of TNFRSF10B protein] | affects localization|decreases reaction | 17876056 |
D010424 | Pentobarbital | Pentobarbital results in decreased expression of TNFRSF10B mRNA | decreases expression | 16978161 |
D011794 | Quercetin | mithramycin A inhibits the reaction [Quercetin results in increased expression of TNFRSF10B mRNA] | decreases reaction|increases expression | 18980244 |
D011794 | Quercetin | Nystatin inhibits the reaction [Quercetin affects the localization of TNFRSF10B protein] | affects localization|decreases reaction | 17876056 |
D011794 | Quercetin | Quercetin affects the localization of TNFRSF10B protein | affects localization | 17876056 |
D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein affects the localization of TNFRSF10B protein] | affects localization|increases reaction | 17876056 |
D011794 | Quercetin | Quercetin results in increased expression of TNFRSF10B mRNA | increases expression | 18980244 |
D011794 | Quercetin | Quercetin results in increased expression of TNFRSF10B protein | increases expression | 18980244 |
D011794 | Quercetin | SP1 protein promotes the reaction [Quercetin results in increased expression of TNFRSF10B mRNA] | increases expression|increases reaction | 18980244 |
C059514 | resveratrol | resveratrol results in increased expression of TNFRSF10B mRNA | increases expression | 12569576 |
C059514 | resveratrol | resveratrol results in increased expression of TNFRSF10B protein | increases expression | 17636462 |
D012643 | Selenium | Selenium results in increased expression of TNFRSF10B protein | increases expression | 12432279 |
C017947 | sodium arsenite | BLVRA protein inhibits the reaction [sodium arsenite results in increased expression of TNFRSF10B mRNA] | decreases reaction|increases expression | 15741166 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of TNFRSF10B mRNA | increases expression | 15741166 |
C025462 | sulindac sulfide | sulindac sulfide inhibits the reaction [PTGS2 protein results in decreased expression of TNFRSF10B mRNA] | decreases expression|decreases reaction | 12208739 |
C025462 | sulindac sulfide | sulindac sulfide results in increased expression of TNFRSF10B mRNA | increases expression | 12203115 11559570 15180942 |
C025462 | sulindac sulfide | sulindac sulfide results in increased expression of TNFRSF10B protein | increases expression | 15180942 |
C025463 | sulindac sulfone | sulindac sulfone results in increased expression of TNFRSF10B mRNA | increases expression | 11559570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of TNFRSF10B mRNA | increases expression | 14718643 12167310 |
D013792 | Thalidomide | Thalidomide results in decreased expression of TNFRSF10B protein | decreases expression | 16531263 |
D014212 | Tretinoin | [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA | affects cotreatment|increases expression | 20349282 |
C012589 | trichostatin A | trichostatin A results in increased expression of TNFRSF10B mRNA | increases expression | 15964798 |
C012589 | trichostatin A | trichostatin A results in increased expression of TNFRSF10B protein | increases expression | 15964798 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of TNFRSF10B mRNA | increases expression | 15964798 |
C088658 | zoledronic acid | [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA | affects cotreatment|increases expression | 20349282 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 15.74 | 12039119 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 15.74 | 14514962 11752688 15322242 | |
MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 15.74 | 8333272 | |
MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 15.74 | 8875741 | |
MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 3.41 | 19490988 | |
MESH:D058186 | Acute Kidney Injury | Folic Acid | 11.68 | 16316344 16595132 17003819 | |
MESH:D058186 | Acute Kidney Injury | resveratrol | 11.68 | 16538975 | |
MESH:D058186 | Acute Kidney Injury | zoledronic acid | 11.68 | 19715164 | |
MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 4.91 | 20200999 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 18.02 | 19825857 11798837 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 18.02 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 18.02 | 16033868 | |
MESH:D000230 | Adenocarcinoma | Doxorubicin | 18.02 | 17418594 | |
MESH:D000230 | Adenocarcinoma | Fenretinide | 18.02 | 10697514 | |
MESH:D000230 | Adenocarcinoma | Fluorouracil | 18.02 | 17638652 | |
MESH:D000230 | Adenocarcinoma | Genistein | 18.02 | 11473722 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 17.24 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 17.24 | 6695378 10737359 | |
MESH:D000236 | Adenoma | Dimethylnitrosamine | 17.24 | 19555203 | |
MESH:D000236 | Adenoma | Folic Acid | 17.24 | 16963246 | |
MESH:D000236 | Adenoma | resveratrol | 17.24 | 15688382 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 8.15 | 17162532 19061943 16434500 19052882 18056438 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 8.15 | 16835633 | |
MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 4.79 | 16150858 | |
MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 4.11 | 15276417 | |
MESH:D018246 | Adrenocortical Adenoma | Arsenic | 11.84 | 17306315 | |
MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 11.84 | 17306315 16712894 | |
MESH:D000419 | Albuminuria | Doxorubicin | 4.00 | 21441931 | |
MESH:D019973 | Alcohol-Related Disorders | Curcumin | 4.50 | 17887948 | |
MESH:D000505 | Alopecia | Tretinoin | 3.15 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Curcumin | 8.12 | 15590663 | |
MESH:D000544 | Alzheimer Disease | Folic Acid | 8.12 | 17116317 | |
MESH:D000544 | Alzheimer Disease | resveratrol | 8.12 | 16183991 16162502 | |
MESH:D000544 | Alzheimer Disease | sulindac sulfide | 8.12 | 18759972 | |
MESH:D000550 | Amblyopia | Valproic Acid | 4.65 | 17688650 | |
MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 3.98 | 16510725 | |
MESH:D000740 | Anemia | Fluorouracil | 7.02 | 16511603 17963324 15504547 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 7.02 | 11748828 | |
MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.72 | 17084956 | |
MESH:D001008 | Anxiety Disorders | Pentobarbital | 7.72 | 11141031 18313124 | |
MESH:D001008 | Anxiety Disorders | Valproic Acid | 7.72 | 17497229 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.51 | 19183758 | |
MESH:D020261 | Arsenic Poisoning | Arsenic | 2.68 | 18414634 16835338 12569548 16251483 | |
MESH:D001169 | Arthritis, Experimental | resveratrol | 10.30 | 17115116 | |
MESH:D001169 | Arthritis, Experimental | Thalidomide | 10.30 | 9598899 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 10.30 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 6.51 | 16807698 | |
MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 6.51 | 17286800 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.51 | 16292516 | |
MESH:D001249 | Asthma | Mustard Gas | 4.27 | 10378619 | |
MESH:D001249 | Asthma | Tretinoin | 4.27 | 16456186 | |
MESH:D001260 | Ataxia Telangiectasia | Quercetin | 4.40 | 15336622 | |
MESH:D050197 | Atherosclerosis | Arsenic | 8.98 | 12928151 19371607 | |
MESH:D050197 | Atherosclerosis | Curcumin | 8.98 | 18704882 | |
MESH:D050197 | Atherosclerosis | resveratrol | 8.98 | 16873680 17967414 | |
MESH:D001321 | Autistic Disorder | Folic Acid | 2.38 | 21388746 | |
MESH:D001321 | Autistic Disorder | Valproic Acid | 2.38 | 18177632 20603192 18558336 17688650 18775368 17157402 16609825 18316065 18940202 17507914 19232924 18985861 19460635 15238991 18396377 | |
MESH:D001327 | Autoimmune Diseases | Curcumin | 9.00 | 19761891 | |
MESH:D001327 | Autoimmune Diseases | Quercetin | 9.00 | 19761891 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.85 | 16935849 | |
MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.76 | 20046352 17594078 | |
MESH:D001768 | Blister | Mustard Gas | 4.58 | 19167455 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 12.36 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 12.36 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 12.36 | 16197459 16206674 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.21 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 6.73 | 15746008 | |
MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 6.73 | 8888407 | |
MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 10.21 | 14601052 | |
MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 10.21 | 14601052 | |
MESH:D001859 | Bone Neoplasms | zoledronic acid | 4.43 | 16778634 15867366 17312309 16121404 19442620 11697798 | |
MESH:D001862 | Bone Resorption | zoledronic acid | 4.19 | 18404659 15845617 8053405 18496637 16769263 11869084 | |
MESH:D002545 | Brain Ischemia | Curcumin | 8.42 | 16770732 | |
MESH:D002545 | Brain Ischemia | resveratrol | 8.42 | 17600658 | |
MESH:D001932 | Brain Neoplasms | Curcumin | 11.90 | 17596214 | |
MESH:D001932 | Brain Neoplasms | Doxorubicin | 11.90 | 17150277 | |
MESH:D001932 | Brain Neoplasms | Fenretinide | 11.90 | 16187019 | |
MESH:D001943 | Breast Neoplasms | alitretinoin | 16.08 | 16344269 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 16.08 | 17474063 20146248 | |
MESH:D001943 | Breast Neoplasms | Curcumin | 16.08 | 19250217 18462866 18593918 16243823 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 16.08 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Doxorubicin | 16.08 | 19526202 16595493 11325840 15668708 17369602 15993339 17983394 15692762 16115903 18695136 16096432 16826403 18628466 15136595 15634643 16322301 16264153 17426702 16935488 18234424 15939500 15567936 18382427 15994142 | |
MESH:D001943 | Breast Neoplasms | Etoposide | 16.08 | 16322251 | |
MESH:D001943 | Breast Neoplasms | Fenretinide | 16.08 | 16601279 | |
MESH:D001943 | Breast Neoplasms | Fluorouracil | 16.08 | 16110121 16595493 19217205 18357371 15136595 16557594 18608205 | |
MESH:D001943 | Breast Neoplasms | Folic Acid | 16.08 | 16777985 | |
MESH:D001943 | Breast Neoplasms | Genistein | 16.08 | 17200150 16873071 16541309 | |
MESH:D001943 | Breast Neoplasms | Methotrexate | 16.08 | 16978400 | |
MESH:D001943 | Breast Neoplasms | Nordihydroguaiaretic Acid | 16.08 | 18418215 | |
MESH:D001943 | Breast Neoplasms | Quercetin | 16.08 | 18628248 | |
MESH:D001943 | Breast Neoplasms | resveratrol | 16.08 | 17534123 16393696 17651959 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 16.08 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 16.08 | 16166294 16443354 16873071 | |
MESH:D001943 | Breast Neoplasms | zoledronic acid | 16.08 | 18695136 16096432 | |
MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 4.58 | 15286001 | |
MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 4.39 | 17687719 10378619 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.01 | 16813970 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.80 | 11589617 | |
MESH:D002105 | Cadmium Poisoning | Quercetin | 4.96 | 16962696 | |
MESH:D002276 | Carcinoid Tumor | Doxorubicin | 10.40 | 16051944 | |
MESH:D002276 | Carcinoid Tumor | Fluorouracil | 10.40 | 16051944 | |
MESH:D002277 | Carcinoma | Curcumin | 16.18 | 18593918 | |
MESH:D002277 | Carcinoma | Dimethylnitrosamine | 16.18 | 19555203 | |
MESH:D002277 | Carcinoma | Fluorouracil | 16.18 | 17121937 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 16.18 | 16835633 | |
MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 3.24 | 15504454 17687452 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.57 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 26.09 | 17306315 16507464 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 26.09 | 16217749 15073043 14691202 11135700 15553829 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 26.09 | 20514400 20524982 18691550 18665156 20214788 11831363 20432363 19822196 17055752 16540662 16328049 19335982 18788625 17978847 16878318 3581430 16681979 3084413 16502159 20512989 16935385 16830150 20727157 19539802 18056438 19418558 19919837 18978308 18506893 20084675 19208518 18494052 10672840 21159647 16569478 16807293 19171122 19519916 17138121 18971187 17761372 17173139 19394651 20101231 16288022 16779866 17162532 19701751 19107877 19383236 17428255 18393292 16698587 20935162 20007298 18210153 18785209 10737359 19052882 | |
MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 26.09 | 18059187 16023760 17876044 16234567 | |
MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 26.09 | 16270382 17159502 | |
MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 26.09 | 18930000 17045692 16799960 16332177 17088986 17971768 | |
MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 26.09 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 26.09 | 12508355 19519916 | |
MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 26.09 | 16227395 19321006 | |
MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 26.09 | 15276417 17306315 16507464 | |
MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 26.09 | 16313753 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 26.09 | 1917145 | |
MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 4.02 | 16675471 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 14.34 | 16052434 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 14.34 | 18414057 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 14.34 | 12391285 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 14.34 | 18758305 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 14.34 | 19233551 | |
MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 4.39 | 17234771 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 4.29 | 19014326 | |
MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 9.18 | 16201981 1485588 | |
MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 9.18 | 18695887 | |
MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 9.18 | 18507039 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.61 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 30.01 | 15504454 17687452 18922899 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 30.01 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 30.01 | 18462866 | |
MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 30.01 | 16033868 | |
MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 30.01 | 6189445 | |
MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 30.01 | 16274795 | |
MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 30.01 | 17066447 18986760 16757204 16280240 | |
MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 30.01 | 16227395 | |
MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 30.01 | 18572023 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 30.01 | 16096774 16051514 | |
MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 3.58 | 18640142 | |
MESH:D006332 | Cardiomegaly | Quercetin | 5.65 | 19794523 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 5.65 | 18670907 18850075 16120746 | |
MESH:D009202 | Cardiomyopathies | Doxorubicin | 3.14 | 17928571 17007740 16278810 16364871 16731534 16651473 15792986 16455267 17382496 16612575 17924179 16242529 17974986 16109756 16952015 15505089 16269455 15476868 15811867 17519947 17131338 17329180 18627295 17351982 17308081 | |
MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.72 | 17334414 16243910 | |
MESH:D002318 | Cardiovascular Diseases | Arsenic | 18.38 | 15738583 19152805 17938729 | |
MESH:D002318 | Cardiovascular Diseases | Folic Acid | 18.38 | 16755160 | |
MESH:D002318 | Cardiovascular Diseases | Genistein | 18.38 | 16332659 | |
MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 18.38 | 16936243 | |
MESH:D002318 | Cardiovascular Diseases | resveratrol | 18.38 | 15458977 | |
MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.82 | 16973168 18022660 | |
MESH:D002386 | Cataract | Tretinoin | 2.73 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 12.64 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 12.64 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 12.64 | 21159647 7505956 17174075 2727394 | |
MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 12.64 | 19524636 20056578 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 11.06 | 16154183 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 11.06 | 16129372 | |
MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.47 | 20734317 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.38 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.38 | 16835633 | |
MESH:D018281 | Cholangiocarcinoma | Thalidomide | 13.38 | 18291259 | |
MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 5.61 | 12912871 | |
MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 6.86 | 7624871 19486331 16629650 15913567 15500046 18590720 12927374 18164287 | |
MESH:D002779 | Cholestasis | Cyclosporine | 6.86 | 19486331 | |
MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 5.27 | 10220858 19407337 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.57 | 16461808 | |
MESH:D002971 | Cleft Lip | Folic Acid | 3.65 | 21254359 | |
MESH:D002972 | Cleft Palate | Folic Acid | 8.29 | 21254359 8946559 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 8.29 | 8697196 12621046 16354765 15340226 15668235 | |
MESH:D002972 | Cleft Palate | Tretinoin | 8.29 | 9407595 | |
MESH:D019970 | Cocaine-Related Disorders | Cocaine | 5.14 | 19606084 | |
MESH:D003092 | Colitis | Curcumin | 23.99 | 18200517 16782535 16804969 | |
MESH:D003092 | Colitis | resveratrol | 23.99 | 16474422 | |
MESH:D003092 | Colitis | Selenium | 23.99 | 17936198 | |
MESH:D003092 | Colitis | Thalidomide | 23.99 | 16680017 | |
MESH:D003092 | Colitis | Tretinoin | 23.99 | 17035595 | |
MESH:D003103 | Coloboma | Curcumin | 4.03 | 18809619 | |
MESH:D003110 | Colonic Neoplasms | marker/mechanism | 19050079 | ||
MESH:D003110 | Colonic Neoplasms | arsenite | 15.05 | 15037631 | |
MESH:D003110 | Colonic Neoplasms | Curcumin | 15.05 | 19359593 16340194 | |
MESH:D003110 | Colonic Neoplasms | Fluorouracil | 15.05 | 17018589 17725105 17172411 16510598 17287894 15001691 16340194 18772588 17169374 17016597 | |
MESH:D003110 | Colonic Neoplasms | Genistein | 15.05 | 17182828 | |
MESH:D003110 | Colonic Neoplasms | Nordihydroguaiaretic Acid | 15.05 | 15936596 | |
MESH:D003110 | Colonic Neoplasms | Quercetin | 15.05 | 16640504 17191121 19440933 19056647 15741050 11134977 17148506 | |
MESH:D003110 | Colonic Neoplasms | resveratrol | 15.05 | 16338953 | |
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 11.33 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 11.33 | 18802399 18259882 | |
MESH:D015179 | Colorectal Neoplasms | Fenretinide | 11.33 | 17273769 | |
MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 11.33 | 20501625 18383874 17695437 14970324 18802399 18448328 16524972 17255274 16282729 17454858 16391804 15289873 17401013 18288408 16331619 18509181 15148649 17594712 18949393 16303861 17094418 17016601 | |
MESH:D015179 | Colorectal Neoplasms | Folic Acid | 11.33 | 17087956 17116713 16963246 17245555 16985020 | |
MESH:D015179 | Colorectal Neoplasms | Quercetin | 11.33 | 18095365 18852136 | |
MESH:D015179 | Colorectal Neoplasms | resveratrol | 11.33 | 16550006 | |
MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 11.33 | 10666051 11197048 18059344 10416599 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.57 | 14669216 17141729 | |
MESH:D016510 | Corneal Neovascularization | Curcumin | 10.74 | 18497527 | |
MESH:D016510 | Corneal Neovascularization | Thalidomide | 10.74 | 9301478 | |
MESH:D003327 | Coronary Disease | resveratrol | 3.36 | 16507316 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.64 | 12609071 | |
MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 5.72 | 9200351 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 8.31 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 8.31 | 9562676 12039119 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 8.31 | 10048152 15322242 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 8.31 | 9200351 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 8.31 | 16925845 10589399 9664655 8800419 9125849 17551590 14991402 9142499 9224671 9211117 | |
MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 8.31 | 16575769 8888407 17688650 | |
MESH:D003424 | Crohn Disease | Thalidomide | 3.86 | 16078585 | |
MESH:D003550 | Cystic Fibrosis | Methotrexate | 3.74 | 19747007 | |
MESH:D007644 | Darier Disease | Fluorouracil | 4.22 | 16733453 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 3.56 | 15213294 | |
MESH:D003882 | Dermatomyositis | Methotrexate | 4.58 | 20191521 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 6.99 | 19496084 | |
MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 6.99 | 16873680 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 11.70 | 18403477 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 11.70 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 11.70 | 16886840 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 11.70 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 11.70 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Curcumin | 7.62 | 18204486 | |
MESH:D003928 | Diabetic Nephropathies | resveratrol | 7.62 | 16286809 | |
MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 15.42 | 18289764 17522070 20133375 7624871 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 15.42 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 15.42 | 8172417 | |
MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 15.42 | 17416283 | |
MESH:D056486 | Drug-Induced Liver Injury | Selenium | 15.42 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 15.42 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 15.42 | 19641884 1733752 | |
MESH:D004362 | Drug Toxicity | Doxorubicin | 6.66 | 18602426 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 6.66 | 11462148 | |
MESH:D004381 | Duodenal Ulcer | Curcumin | 3.51 | 17351913 | |
MESH:D004421 | Dystonia | Valproic Acid | 3.52 | 1851702 | |
MESH:D004487 | Edema | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | 12.41 | 7812673 | |
MESH:D004487 | Edema | Mustard Gas | 12.41 | 11428647 11402378 11428631 9260866 | |
MESH:D004487 | Edema | resveratrol | 12.41 | 8985016 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 12.41 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 10.00 | 16714409 15322242 18230668 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 10.00 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 3.49 | 17872969 | |
MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 5.05 | 19294695 | |
MESH:D004714 | Endometrial Hyperplasia | Genistein | 4.01 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 14.61 | 17359293 | |
MESH:D016889 | Endometrial Neoplasms | Folic Acid | 14.61 | 17301261 | |
MESH:D016889 | Endometrial Neoplasms | Genistein | 14.61 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 14.61 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.52 | 9294722 10568697 | |
MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 4.57 | 18037988 | |
MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 4.29 | 17923197 | |
MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 3.59 | 3659116 17275665 | |
MESH:D004828 | Epilepsies, Partial | Valproic Acid | 3.34 | 16628512 3922381 | |
MESH:D004827 | Epilepsy | Valproic Acid | 2.62 | 20417680 18234410 | |
MESH:D004832 | Epilepsy, Absence | Valproic Acid | 3.10 | 7562514 6254150 6426943 | |
MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 3.74 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 3.49 | 3659116 | |
MESH:D004890 | Erythema | Mustard Gas | 4.58 | 9357497 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.53 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 11.82 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 11.82 | 12903497 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 11.82 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 11.82 | 17016578 | |
MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 11.82 | 16481741 17638652 15173087 16785472 16337965 | |
MESH:D017889 | Exfoliation Syndrome | Folic Acid | 4.92 | 16504073 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 7.38 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 7.38 | 9664655 16938888 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 24.08 | 15073043 | |
MESH:D005234 | Fatty Liver | arsenite | 24.08 | 18296743 | |
MESH:D005234 | Fatty Liver | Curcumin | 24.08 | 19297423 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 24.08 | 19224547 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 24.08 | 20387270 21071580 | |
MESH:D005234 | Fatty Liver | Valproic Acid | 24.08 | 19224547 14986274 | |
MESH:D005264 | Femoral Fractures | zoledronic acid | 5.25 | 16234978 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.90 | 11858732 | |
MESH:D005315 | Fetal Diseases | Valproic Acid | 4.30 | 16575769 | |
MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 3.59 | 8888407 18558336 | |
MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 4.01 | 19069698 | |
MESH:D005355 | Fibrosis | arsenite | 27.28 | 18296743 | |
MESH:D005355 | Fibrosis | Curcumin | 27.28 | 18705752 | |
MESH:D005355 | Fibrosis | Cyclosporine | 27.28 | 12168785 12639820 | |
MESH:D005355 | Fibrosis | Quercetin | 27.28 | 19474275 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 27.28 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 27.28 | 17994277 | |
MESH:D005534 | Foot Diseases | Arsenic | 4.97 | 6392382 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.71 | 16904648 | |
MESH:D005756 | Gastritis | Folic Acid | 4.50 | 17171786 | |
MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 4.13 | 18462866 | |
MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 4.10 | 16452187 | |
MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 5.72 | 12701121 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.64 | 8708960 | |
MESH:D005901 | Glaucoma | Folic Acid | 4.55 | 16504073 | |
MESH:D005909 | Glioblastoma | Curcumin | 27.44 | 17596214 | |
MESH:D005909 | Glioblastoma | Doxorubicin | 27.44 | 17150277 | |
MESH:D005909 | Glioblastoma | Fenretinide | 27.44 | 16187019 | |
MESH:D005909 | Glioblastoma | Genistein | 27.44 | 16598420 | |
MESH:D005909 | Glioblastoma | Quercetin | 27.44 | 19804834 | |
MESH:D005909 | Glioblastoma | Tretinoin | 27.44 | 17312396 | |
MESH:D005909 | Glioblastoma | trichostatin A | 27.44 | 18801729 | |
MESH:D005910 | Glioma | Fluorouracil | 8.54 | 16145905 | |
MESH:D005910 | Glioma | Quercetin | 8.54 | 17643826 | |
MESH:D005910 | Glioma | Thalidomide | 8.54 | 16327979 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.01 | 10696789 | |
MESH:D006086 | Graft vs Host Disease | Methotrexate | 4.59 | 16518429 | |
MESH:D006258 | Head and Neck Neoplasms | Curcumin | 15.15 | 18462866 18829502 | |
MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 15.15 | 15692506 | |
MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 15.15 | 18337622 15102660 15162350 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 15.15 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.57 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 13.27 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Folic Acid | 13.27 | 17286298 16524890 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 13.27 | 11294989 10048152 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 13.27 | 9664655 14991402 | |
MESH:D006331 | Heart Diseases | Doxorubicin | 3.08 | 18006777 16144979 17875725 16707910 16244371 14766674 17888722 16879835 12587719 16495754 18674790 16244372 16330681 | |
MESH:D006333 | Heart Failure | Doxorubicin | 6.00 | 17481944 | |
MESH:D006333 | Heart Failure | Selenium | 6.00 | 17162251 | |
MESH:D006394 | Hemangiosarcoma | Doxorubicin | 3.39 | 15692506 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.85 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.82 | 11000095 | |
MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 4.15 | 18590720 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.34 | 12621046 15340226 16120746 | |
MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 4.48 | 17701891 | |
MESH:D006561 | Herpes Simplex | Etoposide | 8.20 | 10809021 | |
MESH:D006561 | Herpes Simplex | resveratrol | 8.20 | 16876885 | |
MESH:D006679 | HIV Seropositivity | Folic Acid | 4.92 | 17209195 | |
MESH:D006689 | Hodgkin Disease | Doxorubicin | 9.59 | 15147373 17606976 18501091 | |
MESH:D006689 | Hodgkin Disease | Etoposide | 9.59 | 16135485 18180244 15147373 16200630 17606976 | |
MESH:D006689 | Hodgkin Disease | sodium arsenite | 9.59 | 12676792 | |
MESH:D006849 | Hydrocephalus | Valproic Acid | 4.29 | 17688650 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.46 | 18606429 8697196 16959395 15340226 16354765 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 6.67 | 16870215 | |
MESH:D006930 | Hyperalgesia | zoledronic acid | 6.67 | 16769263 | |
MESH:D006934 | Hypercalcemia | bortezomib | 9.72 | 18089816 | |
MESH:D006934 | Hypercalcemia | zoledronic acid | 9.72 | 18089816 19622757 | |
MESH:D006937 | Hypercholesterolemia | Curcumin | 7.67 | 18704882 | |
MESH:D006937 | Hypercholesterolemia | resveratrol | 7.67 | 17188708 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.01 | 16778211 | |
MESH:D006943 | Hyperglycemia | Quercetin | 3.53 | 18262572 11834736 | |
MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 4.01 | 16865747 16433478 16395265 16755160 16397167 | |
MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.95 | 17050553 | |
MESH:D006949 | Hyperlipidemias | resveratrol | 3.50 | 16873680 | |
MESH:D006973 | Hypertension | Arsenic | 10.26 | 9931084 11953799 16076760 | |
MESH:D006973 | Hypertension | Cyclosporine | 10.26 | 10903974 | |
MESH:D006973 | Hypertension | Quercetin | 10.26 | 18356687 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 10.26 | 18850075 18670907 | |
MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.80 | 17488730 | |
MESH:D006987 | Hypesthesia | Arsenic | 4.97 | 16093927 | |
MESH:D006996 | Hypocalcemia | zoledronic acid | 5.61 | 12669777 | |
MESH:D007022 | Hypotension | Isoflurane | 4.41 | 12967683 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 4.09 | 17600658 | |
MESH:D007248 | Infertility, Male | sodium arsenite | 2.60 | 15346721 12646999 | |
MESH:D007249 | Inflammation | Curcumin | 15.70 | 16956363 18403477 17151092 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 15.70 | 18785209 | |
MESH:D007249 | Inflammation | Mustard Gas | 15.70 | 11428647 8975870 16001271 17524151 11428620 9357497 9260866 11428631 11402378 | |
MESH:D007249 | Inflammation | resveratrol | 15.70 | 16366677 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 15.70 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Thalidomide | 15.70 | 16134734 | |
MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.95 | 18596194 18200517 | |
MESH:D007251 | Influenza, Human | Nordihydroguaiaretic Acid | 21.91 | 18473937 | |
MESH:D007251 | Influenza, Human | Quercetin | 21.91 | 16624496 | |
MESH:D007251 | Influenza, Human | resveratrol | 21.91 | 16624496 | |
MESH:D007251 | Influenza, Human | Selenium | 21.91 | 16624496 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.21 | 17994277 | |
MESH:D007414 | Intestinal Neoplasms | Curcumin | 3.72 | 10783313 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.22 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.22 | 17551590 15992940 | |
MESH:D007627 | Keloid | Quercetin | 4.39 | 17086741 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.85 | 15604871 | |
MESH:D007642 | Keratosis | Arsenic | 4.41 | 16930632 12749816 | |
MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 5.06 | 16144296 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 11.55 | 10903974 8314463 18776723 | |
MESH:D007674 | Kidney Diseases | Doxorubicin | 11.55 | 16775033 15369732 15699352 | |
MESH:D007674 | Kidney Diseases | Quercetin | 11.55 | 16962696 | |
MESH:D007674 | Kidney Diseases | sodium arsenite | 11.55 | 20008137 | |
MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 13.76 | 16707910 | |
MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 13.76 | 16518626 | |
MESH:D007676 | Kidney Failure, Chronic | Selenium | 13.76 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 5.84 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | Fluorouracil | 5.84 | 16985049 | |
MESH:D007805 | Language Development Disorders | Methotrexate | 4.57 | 9562676 | |
MESH:D007889 | Leiomyoma | Curcumin | 4.04 | 18555241 | |
MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 3.90 | 16514283 | |
MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 20.52 | 12970779 | |
MESH:D007938 | Leukemia | arsenic trioxide | 20.52 | 15070760 | |
MESH:D007938 | Leukemia | Curcumin | 20.52 | 18462866 | |
MESH:D007938 | Leukemia | Genistein | 20.52 | 17468513 18980019 | |
MESH:D007938 | Leukemia | Quercetin | 20.52 | 17468513 | |
MESH:D007938 | Leukemia | Tretinoin | 20.52 | 17143497 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 4.57 | 16085563 | |
MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | fludarabine | 4.30 | 17296974 17658394 18587576 17802794 18172266 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 19.01 | 12560223 17077332 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 19.01 | 18089816 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 19.01 | 16106398 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 19.01 | 18089816 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 3.73 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 2.99 | 14633726 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 7.76 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 7.76 | 16932348 19285840 16482212 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 12.99 | 17050201 19850784 20471514 16968895 16467208 | |
MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 12.99 | 20471514 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 12.99 | 18720364 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 12.99 | 17596541 16294345 19850784 | |
MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 12.99 | 18206229 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 12.99 | 16294345 17596541 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 14.95 | 17339181 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 14.95 | 16966277 17712046 17869043 15336539 19075265 16330433 11161223 17649720 15213294 15748426 16891316 19642359 12679006 19035177 15622746 12018890 19225113 12712474 17107899 9834237 17217047 16331271 16112521 16823087 11468182 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 14.95 | 16087638 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 14.95 | 16766008 17301526 17368321 17506722 17107899 19225113 17361223 16891316 17649720 16935935 15748426 19075265 16823087 19029980 17294898 12679006 16140955 16331271 19035177 17217047 19642359 9834237 17339181 16788101 17712046 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 9.90 | 16882451 | |
MESH:D015458 | Leukemia, T-Cell | Curcumin | 9.90 | 16106398 | |
MESH:D007972 | Leukoplakia, Oral | Fenretinide | 5.46 | 16707609 | |
MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 7.14 | 10473037 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 7.14 | 9224671 | |
MESH:D008103 | Liver Cirrhosis | arsenite | 13.05 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 13.05 | 18407596 18665156 19638242 20032147 18522880 | |
MESH:D008103 | Liver Cirrhosis | Methotrexate | 13.05 | 14986274 | |
MESH:D008103 | Liver Cirrhosis | Thalidomide | 13.05 | 16943688 17174718 | |
MESH:D008106 | Liver Cirrhosis, Experimental | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 13.70 | 15876570 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 13.70 | 17355460 18006644 18705752 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 13.70 | 15067225 15161499 18672772 15744066 18364076 17724770 17432682 18629640 17201889 17198567 15864749 18567088 15763062 16009107 14709902 17881167 14568256 18637143 15479170 15793283 15383259 15504291 17719030 14643895 18095165 15366600 16627068 16570917 17465448 15339415 16042886 16270385 15099470 18371158 15942678 18210741 17666798 15842777 15492853 15591649 14726149 18237412 17348192 14659978 15081153 16169303 17036385 17196135 15369754 15733078 17534399 12918455 15086199 15577212 17203207 16544323 16603200 15298665 15571005 17640959 18239293 12925901 15723089 15798949 15138612 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 13.70 | 16439617 16595196 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 13.70 | 17823541 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 13.70 | 12741479 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 13.70 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 13.70 | 15465738 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 13.70 | 16248980 18397230 | |
MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 10.55 | 17184895 | |
MESH:D008107 | Liver Diseases | Arsenic | 10.55 | 11134558 | |
MESH:D008107 | Liver Diseases | Curcumin | 10.55 | 16956363 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 10.55 | 17034775 | |
MESH:D008107 | Liver Diseases | Folic Acid | 10.55 | 16877991 | |
MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 3.91 | 17457977 | |
MESH:D008113 | Liver Neoplasms | Arsenic | 28.77 | 16368122 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 28.77 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 28.77 | 21137059 20195826 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 28.77 | 18977376 19833225 19254457 19256749 18978307 19073162 2862719 2422723 19294768 19551842 21071580 20405173 20118626 18644402 20501860 19996281 18648771 19499222 15175105 19690152 19642983 10737359 20101389 19812893 20452335 21167192 20492335 19255062 21278145 18754104 9163691 21047994 20137499 19090486 15885732 19427195 12112319 19426721 20583210 12771043 19638242 16942905 19850985 20434301 | |
MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 28.77 | 15890375 3113478 | |
MESH:D008113 | Liver Neoplasms | Fluorouracil | 28.77 | 18383874 16603448 17045692 15113037 | |
MESH:D008113 | Liver Neoplasms | Quercetin | 28.77 | 18980244 | |
MESH:D008113 | Liver Neoplasms | resveratrol | 28.77 | 19321006 19812893 20405173 19073162 | |
MESH:D008113 | Liver Neoplasms | sodium arsenite | 28.77 | 15276417 16712894 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 28.77 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | therapeutic | 18079962 | ||
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 18.45 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 18.45 | 2563599 9362446 16842330 17174075 18544905 19539802 17942915 19004024 18775883 16267830 18253720 19519916 18282651 19009564 18308698 18164116 21159647 18079962 3124819 18093689 19126423 17854601 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 18.45 | 6150874 15603536 1848544 | |
MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 18.45 | 17085340 16842330 | |
MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 18.45 | 19519916 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 18.45 | 12151625 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.91 | 15213294 | |
MESH:D008171 | Lung Diseases | Mustard Gas | 6.20 | 18702808 18161513 | |
MESH:D008171 | Lung Diseases | sodium arsenite | 6.20 | 19095001 | |
MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 9.52 | 18516814 | |
MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 9.52 | 17228818 | |
MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 3.47 | 17365036 | |
MESH:D008175 | Lung Neoplasms | alitretinoin | 25.92 | 16413115 | |
MESH:D008175 | Lung Neoplasms | Arsenic | 25.92 | 17976673 17306315 19168569 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 25.92 | 11798837 19825857 | |
MESH:D008175 | Lung Neoplasms | arsenite | 25.92 | 16809336 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 25.92 | 20064080 20464547 20869020 18520028 20135361 18816296 6695378 18569708 17053015 | |
MESH:D008175 | Lung Neoplasms | Curcumin | 25.92 | 18462866 16243823 19359593 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 25.92 | 20512841 20970405 6695378 21163286 | |
MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 25.92 | 16061637 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Doxorubicin | 25.92 | 6189445 17418594 | |
MESH:D008175 | Lung Neoplasms | Fluorouracil | 25.92 | 15246190 | |
MESH:D008175 | Lung Neoplasms | Mustard Gas | 25.92 | 3148597 8781369 | |
MESH:D008175 | Lung Neoplasms | Quercetin | 25.92 | 16280456 | |
MESH:D008175 | Lung Neoplasms | sodium arsenite | 25.92 | 15276417 16712894 17077188 19931552 17306315 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 25.92 | 11884234 19555203 | |
MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 4.22 | 15086387 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 3.15 | 17718048 | |
MESH:D008223 | Lymphoma | bortezomib | 23.77 | 16098063 | |
MESH:D008223 | Lymphoma | Chlorambucil | 23.77 | 10745627 | |
MESH:D008223 | Lymphoma | Curcumin | 23.77 | 18462866 | |
MESH:D008223 | Lymphoma | Doxorubicin | 23.77 | 16098063 | |
MESH:D008223 | Lymphoma | Etoposide | 23.77 | 12556972 12854902 | |
MESH:D008223 | Lymphoma | Methotrexate | 23.77 | 17352296 | |
MESH:D016393 | Lymphoma, B-Cell | bortezomib | 8.98 | 16675587 | |
MESH:D016393 | Lymphoma, B-Cell | resveratrol | 8.98 | 17088997 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 7.31 | 17654614 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 7.31 | 14749477 | |
MESH:D016399 | Lymphoma, T-Cell | Curcumin | 9.70 | 16173963 | |
MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 9.70 | 15621674 | |
MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 3.68 | 15688416 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 18.55 | 15458769 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 18.55 | 10697514 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 18.55 | 12929590 14578162 | |
MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 18.55 | 8985016 11606380 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 18.55 | 15318939 | |
MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 18.55 | 17312309 | |
MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 5.12 | 16832597 | |
MESH:D008527 | Medulloblastoma | bortezomib | 6.03 | 19213072 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 6.03 | 17453147 | |
MESH:D008545 | Melanoma | Curcumin | 16.01 | 17885582 18462866 | |
MESH:D008545 | Melanoma | Doxorubicin | 16.01 | 16827129 | |
MESH:D008545 | Melanoma | Fenretinide | 16.01 | 16270382 | |
MESH:D008545 | Melanoma | resveratrol | 16.01 | 17992120 | |
MESH:D008545 | Melanoma | sodium arsenite | 16.01 | 16487513 19082730 | |
MESH:D008545 | Melanoma | Thalidomide | 16.01 | 12829675 16098027 17089043 | |
MESH:D008545 | Melanoma | Tretinoin | 16.01 | 16752155 | |
MESH:D008545 | Melanoma | trichostatin A | 16.01 | 16505122 | |
MESH:D008569 | Memory Disorders | Curcumin | 3.61 | 17263510 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.86 | 16940565 | |
MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 12.40 | 16966607 16166281 18303189 | |
MESH:D008654 | Mesothelioma | Doxorubicin | 12.40 | 17638057 | |
MESH:D008654 | Mesothelioma | Selenium | 12.40 | 15107826 | |
MESH:D008654 | Mesothelioma | zoledronic acid | 12.40 | 16675582 | |
MESH:D008659 | Metabolic Diseases | resveratrol | 3.86 | 17112576 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.20 | 16801185 | |
MESH:D008881 | Migraine Disorders | Valproic Acid | 2.77 | 18803445 18765137 | |
MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.98 | 15792986 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 11.87 | 16381670 | |
MESH:D009062 | Mouth Neoplasms | Fenretinide | 11.87 | 16274795 | |
MESH:D009062 | Mouth Neoplasms | Fluorouracil | 11.87 | 16757204 18986760 | |
MESH:D052016 | Mucositis | Doxorubicin | 10.61 | 17415656 | |
MESH:D052016 | Mucositis | Methotrexate | 10.61 | 17488658 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 27.58 | 14977855 19417148 15949261 11468182 19549372 | |
MESH:D009101 | Multiple Myeloma | bortezomib | 27.58 | 19372569 19112201 19112817 | |
MESH:D009101 | Multiple Myeloma | Curcumin | 27.58 | 19372569 | |
MESH:D009101 | Multiple Myeloma | resveratrol | 27.58 | 17935668 16490592 17049120 17164350 14749477 16267019 | |
MESH:D009101 | Multiple Myeloma | Thalidomide | 27.58 | 15939924 15867202 17168659 15920492 19112201 15744524 16445831 19112817 15741222 19372569 | |
MESH:D009101 | Multiple Myeloma | trichostatin A | 27.58 | 18172295 | |
MESH:D009101 | Multiple Myeloma | zoledronic acid | 27.58 | 16996129 18089719 19621390 | |
MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 10.50 | 17962980 | |
MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 10.50 | 17962980 | |
MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 3.51 | 8888407 | |
MESH:D009181 | Mycoses | Nystatin | 6.19 | 16374455 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 4.09 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 14.70 | 16105982 16882451 | |
MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 14.70 | 18720364 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 14.70 | 17596541 | |
MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 14.70 | 17596541 | |
MESH:D009203 | Myocardial Infarction | Cocaine | 15.00 | 18072171 | |
MESH:D009203 | Myocardial Infarction | Doxorubicin | 15.00 | 15857846 19429709 | |
MESH:D009203 | Myocardial Infarction | Genistein | 15.00 | 17141266 | |
MESH:D009203 | Myocardial Infarction | Quercetin | 15.00 | 19595682 | |
MESH:D009203 | Myocardial Infarction | resveratrol | 15.00 | 16317513 16525036 16456233 17015251 17188708 17125593 | |
MESH:D017202 | Myocardial Ischemia | Arsenic | 12.63 | 15371236 | |
MESH:D017202 | Myocardial Ischemia | resveratrol | 12.63 | 17125593 17015251 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 12.63 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 7.21 | 17141266 | |
MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 7.21 | 19207477 | |
MESH:D009205 | Myocarditis | resveratrol | 4.18 | 17322642 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 8.51 | 16624393 | |
MESH:D009361 | Neoplasm Invasiveness | Curcumin | 8.51 | 18495463 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 8.12 | 9029167 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 8.12 | 18259882 | |
MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 8.12 | 19139120 17312309 15867366 | |
MESH:D009364 | Neoplasm Recurrence, Local | marker/mechanism | 19050079 | ||
MESH:D009369 | Neoplasms | alitretinoin | 19.19 | 16946489 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 19.19 | 11141357 | |
MESH:D009369 | Neoplasms | Fenretinide | 19.19 | 17353921 15958647 | |
MESH:D009369 | Neoplasms | Fluorouracil | 19.19 | 16928823 18239605 18600527 | |
MESH:D009369 | Neoplasms | Quercetin | 19.19 | 15185748 | |
MESH:D009369 | Neoplasms | sodium arsenite | 19.19 | 11559025 | |
MESH:D009369 | Neoplasms | Tretinoin | 19.19 | 16946489 16594593 | |
MESH:D009374 | Neoplasms, Experimental | resveratrol | 7.38 | 8985016 | |
MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 7.38 | 20056578 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 3.95 | 12497104 | |
MESH:D009389 | Neovascularization, Pathologic | arsenite | 3.84 | 15738583 | |
MESH:D009401 | Nephrosis | Doxorubicin | 4.21 | 16636307 16899518 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.85 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 7.67 | 18481113 19348381 | |
MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 7.67 | 15640375 16889571 | |
MESH:D009421 | Nervous System Malformations | Genistein | 19.03 | 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 19.03 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Thalidomide | 19.03 | 16859833 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 19.03 | 9125849 | |
MESH:D009423 | Nervous System Neoplasms | Curcumin | 5.04 | 18462866 | |
MESH:D009436 | Neural Tube Defects | Arsenic | 23.30 | 16620997 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 23.30 | 10525206 | |
MESH:D009436 | Neural Tube Defects | Folic Acid | 23.30 | 17438019 | |
MESH:D009436 | Neural Tube Defects | sodium arsenite | 23.30 | 12854658 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 23.30 | 9142499 | |
MESH:D009436 | Neural Tube Defects | Valproic Acid | 23.30 | 16359493 8888407 | |
MESH:D009447 | Neuroblastoma | Doxorubicin | 2.94 | 15555623 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 6.96 | 20387270 | |
MESH:D019636 | Neurodegenerative Diseases | resveratrol | 6.96 | 17652729 | |
MESH:D020078 | Neurogenic Inflammation | Arsenic | 14.75 | 17056641 | |
MESH:D020078 | Neurogenic Inflammation | Quercetin | 14.75 | 17929310 | |
MESH:D020078 | Neurogenic Inflammation | resveratrol | 14.75 | 17929310 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.53 | 20387270 | |
MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 5.10 | 16303764 | |
MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 3.03 | 16436463 | |
MESH:D009503 | Neutropenia | Folic Acid | 7.84 | 16322990 | |
MESH:D009503 | Neutropenia | Mustard Gas | 7.84 | 16761898 7688884 | |
MESH:D009765 | Obesity | Curcumin | 2.58 | 19297423 | |
MESH:D010014 | Osteolysis | zoledronic acid | 4.80 | 15867366 | |
MESH:D010024 | Osteoporosis | Curcumin | 9.87 | 18719352 | |
MESH:D010024 | Osteoporosis | Genistein | 9.87 | 19401787 | |
MESH:D010024 | Osteoporosis | zoledronic acid | 9.87 | 17882678 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 13.83 | 16169203 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 13.83 | 19495926 | |
MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 13.83 | 17513867 | |
MESH:D012516 | Osteosarcoma | Doxorubicin | 3.65 | 15930896 | |
MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 35.20 | 16211241 | |
MESH:D010051 | Ovarian Neoplasms | Arsenic | 35.20 | 17306315 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 35.20 | 16624393 19769630 12452020 | |
MESH:D010051 | Ovarian Neoplasms | Curcumin | 35.20 | 18462866 19020741 | |
MESH:D010051 | Ovarian Neoplasms | Fenretinide | 35.20 | 16133793 | |
MESH:D010051 | Ovarian Neoplasms | Genistein | 35.20 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Quercetin | 35.20 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 35.20 | 15276417 17306315 | |
MESH:D010051 | Ovarian Neoplasms | Thalidomide | 35.20 | 16288038 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 35.20 | 16936753 | |
MESH:D010051 | Ovarian Neoplasms | trichostatin A | 35.20 | 19331143 | |
MESH:D010146 | Pain | Tretinoin | 5.62 | 16870215 | |
MESH:D010146 | Pain | zoledronic acid | 5.62 | 16475674 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 29.17 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Curcumin | 29.17 | 17440100 19401701 19196508 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 29.17 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Etoposide | 29.17 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 29.17 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 29.17 | 16500647 16929163 15113037 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Quercetin | 29.17 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 29.17 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 29.17 | 19294695 | |
MESH:D010212 | Papilloma | Hydrogen Peroxide | 3.53 | 12065085 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.63 | 19927285 | |
MESH:D010291 | Paresis | Thalidomide | 5.72 | 9200351 | |
MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 11.84 | 20133375 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 11.84 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.64 | 16093927 | |
MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 4.41 | 16905509 6392382 15371236 | |
MESH:D010538 | Peritonitis | Isoflurane | 4.67 | 17414419 | |
MESH:D003557 | Phyllodes Tumor | Doxorubicin | 4.57 | 17983394 | |
MESH:D010954 | Plasmacytoma | Selenium | 4.30 | 15087411 | |
MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 4.33 | 10923243 | |
MESH:D010997 | Pleural Neoplasms | Doxorubicin | 4.57 | 17638057 | |
MESH:D011041 | Poisoning | Mustard Gas | 3.28 | 15727166 | |
MESH:D017499 | Porokeratosis | alitretinoin | 5.42 | 16144296 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.01 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 12.50 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 12.50 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Quercetin | 12.50 | 19056647 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 3.88 | 17031469 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 12.96 | 16679765 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 12.96 | 11222880 11399792 11896295 11118676 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 12.96 | 20603192 | |
MESH:D055728 | Primary Myelofibrosis | trichostatin A | 4.69 | 17616702 | |
MESH:D011471 | Prostatic Neoplasms | Arsenic | 9.23 | 16140617 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 9.23 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 9.23 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Curcumin | 9.23 | 10851300 18226269 15129424 11398177 18156803 18769126 12497104 | |
MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 9.23 | 15749863 18437689 16729912 15897917 16888761 16868541 | |
MESH:D011471 | Prostatic Neoplasms | Etoposide | 9.23 | 17172428 | |
MESH:D011471 | Prostatic Neoplasms | Fenretinide | 9.23 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 9.23 | 18626508 19082440 | |
MESH:D011471 | Prostatic Neoplasms | Genistein | 9.23 | 15256057 15378649 16925846 | |
MESH:D011471 | Prostatic Neoplasms | Nordihydroguaiaretic Acid | 9.23 | 18491370 | |
MESH:D011471 | Prostatic Neoplasms | Quercetin | 9.23 | 17292933 14715546 | |
MESH:D011471 | Prostatic Neoplasms | resveratrol | 9.23 | 17804756 17675339 17718901 17636462 16731767 15767336 | |
MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 9.23 | 16039940 | |
MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 9.23 | 17908994 15570007 | |
MESH:D011471 | Prostatic Neoplasms | Thalidomide | 9.23 | 16729912 | |
MESH:D011471 | Prostatic Neoplasms | trichostatin A | 9.23 | 19789329 18798265 | |
MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 9.23 | 12438248 19103299 | |
MESH:D011507 | Proteinuria | Arsenic | 7.52 | 21343184 | |
MESH:D011507 | Proteinuria | Tretinoin | 7.52 | 16636307 | |
MESH:D011536 | Prurigo | Thalidomide | 5.72 | 12755975 | |
MESH:D011537 | Pruritus | Mustard Gas | 3.52 | 18058305 | |
MESH:D019310 | Pseudolymphoma | Valproic Acid | 3.96 | 12752131 11422049 | |
MESH:D011565 | Psoriasis | Cyclosporine | 5.12 | 16882103 | |
MESH:D011565 | Psoriasis | Methotrexate | 5.12 | 17410198 | |
MESH:D011618 | Psychotic Disorders | Cocaine | 4.40 | 16134406 | |
MESH:D011625 | Pterygium | Tretinoin | 4.22 | 16723453 | |
MESH:D011656 | Pulmonary Emphysema | Curcumin | 4.02 | 19168576 | |
MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 5.06 | 17975199 15814490 17322281 17365031 | |
MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 5.06 | 17894541 10334151 17266442 17720292 17620002 | |
MESH:D012004 | Rectal Neoplasms | Fluorouracil | 3.52 | 18722050 15538739 16160472 18286688 | |
MESH:D012021 | Reflex, Abnormal | Pentobarbital | 5.45 | 10930210 | |
MESH:D051437 | Renal Insufficiency | Doxorubicin | 14.07 | 17922066 | |
MESH:D051437 | Renal Insufficiency | Folic Acid | 14.07 | 15728788 | |
MESH:D051437 | Renal Insufficiency | Methotrexate | 14.07 | 17352296 | |
MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 5.00 | 16325855 | |
MESH:D015427 | Reperfusion Injury | resveratrol | 2.97 | 16317513 17520802 17058453 16314181 15827377 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 3.50 | 10666014 18379247 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.29 | 18990726 | |
MESH:D012162 | Retinal Degeneration | Fenretinide | 3.96 | 16303925 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 9.10 | 16283617 16116481 | |
MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 9.10 | 19155313 | |
MESH:D012509 | Sarcoma | Curcumin | 7.90 | 18462866 | |
MESH:D012509 | Sarcoma | Doxorubicin | 7.90 | 17710206 15675481 15625365 17203757 16767912 18313854 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 20.18 | 16646077 | |
MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 20.18 | 14601052 16326096 | |
MESH:D012512 | Sarcoma, Ewing's | Etoposide | 20.18 | 14601052 | |
MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 20.18 | 16121404 | |
MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 4.22 | 17846226 | |
MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.96 | 16862918 | |
MESH:D012559 | Schizophrenia | Folic Acid | 3.51 | 16641680 | |
MESH:D012559 | Schizophrenia | Valproic Acid | 3.51 | 19110320 15737665 | |
MESH:D019873 | Schnitzler Syndrome | Thalidomide | 5.36 | 16096327 | |
MESH:D012640 | Seizures | Cocaine | 7.86 | 10454489 | |
MESH:D012640 | Seizures | Pentobarbital | 7.86 | 10087439 9754883 | |
MESH:D012640 | Seizures | Valproic Acid | 7.86 | 17978042 14763951 3137016 16876388 1511512 15475178 11044598 11738929 | |
MESH:D018805 | Sepsis | Curcumin | 8.23 | 18389075 | |
MESH:D018805 | Sepsis | Isoflurane | 8.23 | 17414419 | |
MESH:D012871 | Skin Diseases | Arsenic | 7.01 | 6392382 16353154 16702368 17050553 16759981 15952646 19834688 18709164 17453740 17938729 17548696 | |
MESH:D012871 | Skin Diseases | Folic Acid | 7.01 | 18709164 | |
MESH:D012871 | Skin Diseases | Mustard Gas | 7.01 | 12880345 16961503 15451306 | |
MESH:D012878 | Skin Neoplasms | Arsenic | 31.06 | 17029826 17050553 16251483 15504454 19538983 17976673 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 31.06 | 19755658 10029692 | |
MESH:D012878 | Skin Neoplasms | Doxorubicin | 31.06 | 15692506 | |
MESH:D012878 | Skin Neoplasms | Fenretinide | 31.06 | 16467112 | |
MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 31.06 | 12065085 | |
MESH:D012878 | Skin Neoplasms | resveratrol | 31.06 | 8985016 15837718 | |
MESH:D012878 | Skin Neoplasms | sodium arsenite | 31.06 | 19524636 18572023 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 31.06 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 31.06 | 16467112 | |
MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 4.01 | 15625365 17203757 16767912 | |
MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.92 | 16361298 | |
MESH:D016135 | Spinal Dysraphism | sodium arsenite | 8.04 | 12854658 | |
MESH:D016135 | Spinal Dysraphism | Valproic Acid | 8.04 | 19490988 | |
MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 4.68 | 12587719 | |
OMIM:275355 | SQUAMOUS CELL CARCINOMA, HEAD AND NECK | marker/mechanism | |||
MESH:D013226 | Status Epilepticus | Valproic Acid | 3.96 | 12833885 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 9.11 | 17007042 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 9.11 | 20155912 2093021 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 9.11 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 9.11 | 16033868 | |
MESH:D013274 | Stomach Neoplasms | Fluorouracil | 9.11 | 16951190 18396642 19084572 18567086 15786421 17522103 19015929 16424979 17498489 17172411 | |
MESH:D013274 | Stomach Neoplasms | Folic Acid | 9.11 | 17171786 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 9.11 | 17261132 | |
MESH:D013276 | Stomach Ulcer | Curcumin | 6.11 | 19188055 16631530 | |
MESH:D013276 | Stomach Ulcer | Thalidomide | 6.11 | 15138204 | |
MESH:D020521 | Stroke | Folic Acid | 3.87 | 16517955 | |
OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.98 | 16321402 | |
MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 4.48 | 9754883 11529278 | |
MESH:D013576 | Syndactyly | Methotrexate | 4.49 | 9562676 | |
MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 4.25 | 20133375 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.32 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 13.47 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 13.47 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 13.47 | 16010429 17909728 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 13.47 | 17045167 16026305 | |
MESH:D014062 | Tongue Neoplasms | Fluorouracil | 13.68 | 16280240 | |
MESH:D014062 | Tongue Neoplasms | resveratrol | 13.68 | 16227395 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 13.68 | 16051514 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.39 | 15213294 | |
MESH:D014178 | Translocation, Genetic | Valproic Acid | 4.65 | 17262798 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.85 | 16040207 | |
MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.95 | 3119515 | |
MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 23.91 | 11144890 19429237 17306315 18640142 19322015 15987713 17976673 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 23.91 | 20435036 12973940 12845720 11780464 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 23.91 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 23.91 | 18593936 | |
MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 23.91 | 17653716 | |
MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 23.91 | 16720286 | |
MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 23.91 | 16720314 | |
MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 23.91 | 11723127 16452187 16712894 17306315 | |
MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 4.08 | 8888407 | |
MESH:D014565 | Urogenital Neoplasms | Curcumin | 4.69 | 18462866 | |
MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 24.35 | 16154183 | |
MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 24.35 | 16803524 | |
MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 24.35 | 17473185 | |
MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 24.35 | 11813266 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 24.35 | 16129372 | |
MESH:D014594 | Uterine Neoplasms | resveratrol | 8.19 | 17044934 | |
MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 8.19 | 18645019 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.02 | 16752155 | |
MESH:D014605 | Uveitis | Cyclosporine | 3.40 | 1336536 | |
MESH:D014652 | Vascular Diseases | Arsenic | 16.93 | 17056641 | |
MESH:D014652 | Vascular Diseases | sodium arsenite | 16.93 | 17056641 | |
MESH:D014652 | Vascular Diseases | Thalidomide | 16.93 | 15741222 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.01 | 12125929 | |
MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 8.48 | 17638931 16364871 17678736 17334414 | |
MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 8.48 | 17488730 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.51 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.66 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.48 | 16287080 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 3.85 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:04210 | Apoptosis |
REACT:578 | Apoptosis |
KEGG:04060 | Cytokine-cytokine receptor interaction |
KEGG:05162 | Measles |
KEGG:04650 | Natural killer cell mediated cytotoxicity |
KEGG:04115 | p53 signaling pathway |